Clinical Trials Browser

Colorectal Neoplasms × irinotecan sucrosofate × 90 days × Clear all

NCT05854498 2026-04-02

Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer

Phase 2 Recruiting

Gastrointestinal

Colorectal Neoplasms